Viela Bio, Inc.
Overview
Viela Bio, Inc. is a biotechnology company focused on developing treatments for severe inflammation and autoimmune diseases. It was acquired by Horizon Therapeutics in 2021 and now operates as a subsidiary.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Viela Bio, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
3t Biosciences
United States
American Cyanamid Company (as Wyeth-Ayerst Laboratories)
United States
Amgen Inc.
United States
AutoImmune Research Institute
USA
Biora Therapeutics, Inc.
United States
Chemeleon, Inc.
United States
Cour Pharmaceuticals Development Company, Inc.
United States
Cytonics Corporation
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.